VR Therapy for Dementia
(VR&R Trial)
Trial Summary
Do I need to stop my current medications for the VR Therapy for Dementia trial?
The trial protocol does not specify whether you need to stop taking your current medications. It seems likely that you can continue your medications, but please confirm with the trial organizers.
What data supports the effectiveness of the treatment Immersive VR Therapy in Head-Mounted Device (HMD) for dementia?
Research shows that virtual reality (VR) can improve emotional wellbeing and reduce apathy in people with dementia, making it a promising tool for enhancing quality of life. Studies have found VR to be safe, enjoyable, and engaging, although its impact on physical aspects like balance and mobility is less clear.12345
Is VR therapy safe for people with dementia?
How is Immersive VR Therapy in Head-Mounted Device (HMD) different from other treatments for dementia?
Immersive VR Therapy using a head-mounted device is unique because it provides a non-drug approach to dementia care, focusing on enhancing emotional well-being and engagement through virtual environments. Unlike traditional treatments, it allows people with dementia to interact with realistic simulations, which can promote reminiscence and improve mood without significant side effects.14789
What is the purpose of this trial?
The goal of this interventional trial is to learn about how immersive Virtual Reality (VR) therapy can be used at home by individuals with dementia, with assistance from their informal (e.g., friend/family) caregivers.The main question it aims to answer are:1. Can caregivers receive quality respite time by using VR-therapy at home with their loved ones with dementia? Does this intervention reduce feelings of burden and improve well-being and resilience for caregivers?2. Does VR-therapy help to manage behavioural and psychological symptoms (e.g., mood, apathy, agitation) and improve quality of life for individuals with dementia?3. What types of VR "medium" (passive or cooperative) are most effective for achieving the above objectives?Participant pairs will be asked to:* Take part in an initial at-home VR technology training session and complete a series of brief questionnaires (e.g., health history/technology use, well-being/quality of life, symptoms of dementia)* Use "VR\&R" (VR Rest \& Relaxation Therapy) for a period of 4 weeks (30 minute sessions, desired frequency), and answer a brief set of questions after each VR\&R session* Provide feedback on the VR\&R intervention in semi-structured interview with the researcher and answer additional questionnaires at a 2-week follow-upDuring VR\&R sessions, participants with dementia will have the opportunity to choose to watch (1) immersive 360-degree videos (e.g., of a live performance, or beach) on their own and (2) experience the same VR videos together with a researcher.Caregivers will be asked to assist their loved one with dementia to use VR\&R by helping to put on the VR headset, selecting a VR experience through a user-friendly application, and remaining nearby to supervise and provide assistance as needed. During VR\&R sessions, caregivers may use this time to take a personal break or complete short tasks (e.g., make a cup of coffee, have an uninterrupted phone call).
Eligibility Criteria
This trial is for people with dementia aged 65 or older living at home with a family caregiver who can access the internet. Caregivers should be able to speak and understand English, provide consent, and assist their loved one. Excluded are those with certain legal guardianships, language barriers, pacemakers, blindness, open facial wounds (except sutured lacerations), seizure history, recent head trauma or stroke, unsafe cervical conditions for VR use, or alcohol-related dementia.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Initial Training
Participants take part in an initial at-home VR technology training session and complete a series of brief questionnaires
VR Therapy
Participants use VR&R therapy for a period of 4 weeks, with sessions lasting 30 minutes each
Follow-up
Participants provide feedback on the VR&R intervention in semi-structured interviews and answer additional questionnaires
Treatment Details
Interventions
- Immersive VR Therapy in Head-Mounted Device (HMD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Health Network, Toronto
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator
Centre for Aging and Brain Health Innovation
Collaborator
Ontario AHSC AFP Innovation Fund
Collaborator